RE: add primarybs102 interesting find inequities.
here is one of primarybs102's gems about the 2003 AGM
2003/05/29 09:30, Post ID:926 primarybs102
Subject:Annual General Meeting
I concur with everything that was said about the AGM namely:
1. Reolysin appears effective in the treatment of cancer;
2. that phase II prostate results are expected anytime soon;
3. that the glioma clinical trial results are expected this year;
4. that trial costs are at a minimal due to the high number of patients showing significant results;
5. that the company has enough money to last them although a small PP may be implemented;
6. that a partnership is "imminent";
7. that systemic trials will begin later this year.
sounds strangely familiar...something that dozens of other aliases have spouted about seemingly every onc AGM since 2001...
i am hoping we can come up with the name of BIOEYE/confucus/whosyurdaddy in time for the AGM...so that Brad Thompson & Matt Coffey can address questions about their "relationship" with this imposter in front of many potential witnesses...
the fact someone went to great lengths to get you off of yahoo just shows how desperate they have become...are we getting too close to exposing this person?????
funny thing is, we have still only scratched the surface...and by continuing their desperate and despicable threats and attempts to censor posts and posters, they are only going to attract a whole lot more "unwanted attention" to themselves, Brad Thompson, Matthew Coffey & oncolytics biotech.
i think management is getting a bit desperate too - i think they are starting to realize the time they have left to justify their inflated scientific egos, inflated number of low-priced onc options and lack of trial progress (apparently due to enrolment problems for this supposed safe & revolutionary reovirus) is fast running out.
will a last ditch pump be successful, knowing there is nothing of real substance on the horizon to sustain it?
will the first US patient enrolled in the glio trial coincide with the day of the AGM again this year, so they have a news release to appease some of the more restless cult members?
will they cut short the Cdn glio trial (like they apparently did with the ph II prostate trial) so they can announce interim/final results and try to placate shareholder anger for the lack of progress?
what other possible half-measure can they make appear as "tangible progress" to avoid being repeatedly grilled?
shareholders have every reason to be increasingly doubtful of this management - repeated failure to deliver results while repeatedly delivering themselves huge and unjustifiable stock based & other compensation - they have earned the skepticism in which they are held by more and more objective shareholders.
i think the fun is just beginning!
